Calidi Biotherapeutics Inc
CLDI0.602USD
+0.012+1.97%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
19.14MMarket Cap
LossP/E TTM
Calidi Biotherapeutics Inc
0.602
+0.012+1.97%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Total equity
Cash, cash equivalents and short-term investments
823.97%10.56M
392.10%9.59M
-81.30%1.90M
-56.41%836.00K
24.37%1.14M
423.92%1.95M
4973.50%10.15M
--1.92M
--919.00K
--372.00K
--200.00K
- Cash and cash equivalents
823.97%10.56M
392.10%9.59M
-81.30%1.90M
-56.41%836.00K
24.37%1.14M
423.92%1.95M
4973.50%10.15M
--1.92M
--919.00K
--372.00K
--200.00K
Receivables
--50.00K
--0.00
----
--181.00K
----
----
----
----
----
----
----
-Other receivables
--50.00K
--0.00
----
--181.00K
----
----
----
----
----
----
----
Prepaid expenses
-24.84%596.00K
-83.56%387.00K
-92.99%108.00K
-54.83%402.00K
72.77%793.00K
468.60%2.35M
492.31%1.54M
--890.00K
--459.00K
--414.00K
--260.00K
Other current assets
--282.00K
--249.00K
--216.00K
--206.00K
----
----
----
----
----
----
----
Total current assets
493.44%11.49M
137.67%10.23M
-81.00%2.22M
-42.13%1.63M
40.49%1.94M
447.46%4.30M
2440.65%11.69M
--2.81M
--1.38M
--786.00K
--460.00K
Non-current assets
Net Fixed Assets
-30.87%3.43M
-28.82%3.80M
-22.76%4.22M
-20.12%4.58M
-17.46%4.96M
391.99%5.34M
442.40%5.46M
--5.73M
--6.01M
--1.09M
--1.01M
-Fixed Assets
-19.04%4.90M
-18.59%5.16M
-13.13%5.52M
-11.95%5.76M
-9.93%6.05M
269.02%6.34M
313.34%6.35M
--6.54M
--6.72M
--1.72M
--1.54M
-Accumulated depreciation
34.99%1.47M
36.46%1.35M
45.90%1.30M
45.63%1.18M
54.48%1.09M
57.37%993.00K
68.11%891.00K
--813.00K
--703.00K
--631.00K
--530.00K
Other non-current assets
-71.54%144.00K
6.29%152.00K
46.62%217.00K
--227.00K
--506.00K
--143.00K
--148.00K
----
----
----
----
Total non-current assets
-34.63%3.58M
-30.81%3.96M
-35.71%4.44M
-34.80%4.81M
-20.52%5.47M
215.63%5.72M
495.85%6.90M
--7.37M
--6.88M
--1.81M
--1.16M
Total assets
103.43%15.06M
41.55%14.18M
-64.18%6.66M
-36.82%6.43M
-10.34%7.41M
285.79%10.02M
1048.76%18.59M
--10.18M
--8.26M
--2.60M
--1.62M
Liabilities
Current liabilities
-Other payables
-98.94%7.00K
690.12%640.00K
665.43%620.00K
-98.40%684.00K
-97.96%661.00K
-99.73%81.00K
-99.67%81.00K
--42.75M
--32.42M
--29.98M
--24.36M
Accrued expenses
-65.35%1.77M
-56.96%2.34M
-38.51%3.06M
-45.76%3.74M
-13.38%5.10M
1.59%5.43M
-2.62%4.98M
--6.89M
--5.89M
--5.35M
--5.12M
Short-term debt and lease liabilities
-72.13%1.20M
265.09%3.24M
-7.28%3.16M
-67.66%3.05M
-47.46%4.31M
-83.85%888.00K
-16.84%3.41M
--9.43M
--8.20M
--5.50M
--4.10M
-Short-term debt
----
----
----
----
----
-100.00%0.00
-65.79%1.02M
--3.47M
--3.33M
--2.96M
--2.98M
-Short-term lease liabilities
-6.76%69.00K
-18.52%66.00K
11.29%69.00K
-2.86%68.00K
4.23%74.00K
12.50%81.00K
31.91%62.00K
--70.00K
--71.00K
--72.00K
--47.00K
Other current liabilities
-98.94%7.00K
690.12%640.00K
665.43%620.00K
-98.40%684.00K
-97.96%661.00K
-99.73%81.00K
-99.67%81.00K
--42.75M
--32.42M
--29.98M
--24.36M
Total current liabilities
-63.71%5.43M
-7.19%9.50M
6.49%11.58M
-78.47%13.05M
-69.99%14.95M
-76.20%10.23M
-69.57%10.87M
--60.63M
--49.83M
--42.99M
--35.73M
Non-current liabilities
Long-term debt and lease liabilities
-65.37%2.12M
-52.03%2.44M
-13.69%4.53M
23.69%4.39M
61.43%6.13M
1571.15%5.10M
3355.92%5.25M
--3.55M
--3.80M
--305.00K
--152.00K
-Long-term debt
-82.22%600.00K
-70.87%600.00K
21.44%2.37M
--1.93M
--3.38M
--2.06M
--1.95M
----
----
----
----
-Long-term lease liabilities
-44.74%1.52M
-39.25%1.84M
-34.50%2.16M
-30.60%2.46M
-27.44%2.76M
895.74%3.04M
2070.39%3.30M
--3.55M
--3.80M
--305.00K
--152.00K
Other non-current liabilities
-87.52%87.00K
-95.28%128.00K
-94.91%176.00K
--565.00K
--697.00K
--2.71M
--3.46M
----
----
----
----
Total non-current liabilities
-66.70%2.34M
-66.12%2.72M
-44.64%4.88M
40.34%5.13M
79.03%7.03M
1694.63%8.02M
3958.99%8.81M
--3.66M
--3.92M
--447.00K
--217.00K
Total liabilities
-64.67%7.76M
-33.09%12.21M
-16.39%16.45M
-71.72%18.18M
-59.11%21.98M
-57.97%18.25M
-45.24%19.68M
--64.29M
--53.75M
--43.44M
--35.94M
Shareholders' equity
Common equity
44.96%133.67M
34.90%123.28M
19.01%107.41M
293.49%100.84M
324.24%92.21M
358.52%91.38M
382.51%90.25M
--25.63M
--21.74M
--19.93M
--18.70M
Preferred equity
----
----
----
----
----
----
----
--9.60M
--9.60M
--9.60M
--9.60M
Retained earnings
-18.64%-126.70M
-22.24%-121.72M
-28.77%-117.62M
-26.02%-112.56M
-39.03%-106.80M
-41.53%-99.57M
-45.92%-91.34M
---89.32M
---76.82M
---70.36M
---62.60M
Capital reserves
44.96%133.66M
34.90%123.28M
19.01%107.41M
293.51%100.84M
324.26%92.21M
358.55%91.38M
382.54%90.25M
--25.63M
--21.73M
--19.93M
--18.70M
Gains losses not affecting retained earnings
-336.36%-26.00K
40.43%-28.00K
-1750.00%-74.00K
-58.82%-27.00K
191.67%11.00K
-235.71%-47.00K
87.10%-4.00K
---17.00K
---12.00K
---14.00K
---31.00K
Non-controlling interests
--358.00K
--434.00K
--485.00K
----
----
----
----
----
----
----
----
Total equity
150.09%7.30M
123.90%1.97M
-795.61%-9.80M
78.28%-11.75M
67.97%-14.57M
79.84%-8.23M
96.81%-1.09M
---54.11M
---45.49M
---40.84M
---34.33M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
